We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
Westrock Coffee
WEST
$969M
| $3.83M | ﹤0.01% |
472,859
+366,963
| +347% | +$2.63M |
2025 Q1
5 quarters
|
|
2177
KRONOS Worldwide
KRO
$863M
| $3.83M | ﹤0.01% |
604,734
+295,971
| +96% | +$2.03M |
2024 Q2
8 quarters
|
|
2178
Critical Metals Corp
CRML
$1.06B
| $3.83M | ﹤0.01% |
373,429
-47,017
| -11% | -$503K |
2025 Q1
5 quarters
|
|
2179
Dole
DOLE
$1.23B
| $3.82M | ﹤0.01% |
278,624
+84,833
| +44% | +$1.23M |
2024 Q2
8 quarters
|
|
2180
BNY Mellon US Large Cap Core Equity ETF
BKLC
$6.77B
| $3.82M | ﹤0.01% |
79,875
-102
| -0.1% | -$4.72K |
2025 Q4
2 quarters
|
|
2181
Traeger
COOK
$148M
| $3.8M | ﹤0.01% |
+48,218
| New | +$2.51M |
2026 Q2
0 quarters
|
|
2182
JBT Marel
JBTM
$5.66B
| $3.8M | ﹤0.01% |
26,176
-2,730
| -9% | -$353K |
2024 Q2
8 quarters
|
|
2183
AGNC Investment
AGNC
$10.3B
| $3.79M | ﹤0.01% |
347,508
+8,117
| +2% | +$85.5K |
2024 Q2
8 quarters
|
|
2184
Upstream Bio Inc
UPB
$187M
| $3.77M | ﹤0.01% |
544,869
+472,698
| +655% | +$3.96M |
2025 Q1
5 quarters
|
|
2185
Belden
BDC
$4.13B
| $3.76M | ﹤0.01% |
31,748
-6,913
| -18% | -$806K |
2019 Q1
29 quarters
|
|
2186
Universal Corp
UVV
$1.03B
| $3.76M | ﹤0.01% |
72,121
+33,665
| +88% | +$1.79M |
2021 Q4
18 quarters
|
|
2187
Apollo Commercial Real Estate
ARI
$300M
| $3.76M | ﹤0.01% |
352,161
+30,617
| +10% | +$334K |
2015 Q4
42 quarters
|
|
2188
Immersion
IMMR
$239M
| $3.76M | ﹤0.01% |
555,332
+257,551
| +86% | +$1.62M |
2023 Q3
11 quarters
|
|
2189
PubMatic
PUBM
$724M
| $3.76M | ﹤0.01% |
286,438
+161,484
| +129% | +$1.68M |
2026 Q1
1 quarter
|
|
2190
Celanese
CE
$5.41B
| $3.75M | ﹤0.01% |
81,483
-35,050
| -30% | -$2.03M |
2013 Q2
52 quarters
|
|
2191
Enanta Pharmaceuticals
ENTA
$312M
| $3.75M | ﹤0.01% |
256,870
-56,287
| -18% | -$757K |
2014 Q2
48 quarters
|
|
2192
Expensify
EXFY
$214M
| $3.73M | ﹤0.01% |
2,085,857
+1,259,624
| +152% | +$1.41M |
2025 Q3
3 quarters
|
|
2193
Xperi
XPER
$260M
| $3.73M | ﹤0.01% |
452,848
+2,000
| +0.4% | +$14.5K |
2024 Q1
9 quarters
|
|
2194
Woori Financial
WF
$16.4B
| $3.73M | ﹤0.01% |
64,913
+12,144
| +23% | +$788K |
2024 Q3
7 quarters
|
|
2195
Mirion Technologies
MIR
$4.51B
| $3.72M | ﹤0.01% |
207,596
-61,476
| -23% | -$1.14M |
2024 Q4
6 quarters
|
|
2196
Motorcar Parts of America
MPAA
$195M
| $3.72M | ﹤0.01% |
242,774
-65,855
| -21% | -$797K |
2025 Q3
3 quarters
|
|
2197
Cartesian Therapeutics
RNAC
$196M
| $3.71M | ﹤0.01% |
356,456
+272,436
| +324% | +$2.02M |
2026 Q1
1 quarter
|
|
2198
Altimmune
ALT
$397M
| $3.71M | ﹤0.01% |
1,220,949
+1,135,495
| +1,329% | +$3.39M |
2025 Q4
2 quarters
|
|
2199
Vanguard Russell 1000 Value ETF
VONV
$22.6B
| $3.7M | ﹤0.01% |
34,826
+10,896
| +46% | +$1.11M |
2024 Q3
7 quarters
|
|
2200
Ooma
OOMA
$550M
| $3.69M | ﹤0.01% |
191,849
+2,552
| +1% | +$43.8K |
2025 Q1
5 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.